BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 15383272)

  • 1. JNKing Revealed.
    Ronai Z
    Mol Cell; 2004 Sep; 15(6):843-4. PubMed ID: 15383272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation.
    Sabapathy K; Hochedlinger K; Nam SY; Bauer A; Karin M; Wagner EF
    Mol Cell; 2004 Sep; 15(5):713-25. PubMed ID: 15350216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.
    Liu J; Minemoto Y; Lin A
    Mol Cell Biol; 2004 Dec; 24(24):10844-56. PubMed ID: 15572687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of JNK1 and JNK2 on signal specific induction of apoptosis.
    Hochedlinger K; Wagner EF; Sabapathy K
    Oncogene; 2002 Apr; 21(15):2441-5. PubMed ID: 11948429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of fibroblast collagenase-1 expression by tumor cells of squamous cell carcinomas is mediated by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase-2.
    Westermarck J; Li S; Jaakkola P; Kallunki T; Grénman R; Kähäri VM
    Cancer Res; 2000 Dec; 60(24):7156-62. PubMed ID: 11156425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for c-Jun N-terminal kinase 1 (JNK1), but not JNK2, in the beta-amyloid-mediated stabilization of protein p53 and induction of the apoptotic cascade in cultured cortical neurons.
    Fogarty MP; Downer EJ; Campbell V
    Biochem J; 2003 May; 371(Pt 3):789-98. PubMed ID: 12534344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms.
    David JP; Sabapathy K; Hoffmann O; Idarraga MH; Wagner EF
    J Cell Sci; 2002 Nov; 115(Pt 22):4317-25. PubMed ID: 12376563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TBP is differentially regulated by c-Jun N-terminal kinase 1 (JNK1) and JNK2 through Elk-1, controlling c-Jun expression and cell proliferation.
    Zhong S; Fromm J; Johnson DL
    Mol Cell Biol; 2007 Jan; 27(1):54-64. PubMed ID: 17074809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Jun N-terminal kinase/c-Jun inhibits fibroblast proliferation by negatively regulating the levels of stathmin/oncoprotein 18.
    Yeap YY; Ng IH; Badrian B; Nguyen TV; Yip YY; Dhillon AS; Mutsaers SE; Silke J; Bogoyevitch MA; Ng DC
    Biochem J; 2010 Sep; 430(2):345-54. PubMed ID: 20594188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential gene expression profiles of Jnk1- and Jnk2-deficient murine fibroblast cells.
    Chen N; She QB; Bode AM; Dong Z
    Cancer Res; 2002 Mar; 62(5):1300-4. PubMed ID: 11888895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of c-Jun N-terminal kinase regulation and function.
    Hall JP; Davis RJ
    Methods Enzymol; 2002; 345():413-25. PubMed ID: 11665625
    [No Abstract]   [Full Text] [Related]  

  • 12. The stress-activated protein kinase subfamily of c-Jun kinases.
    Kyriakis JM; Banerjee P; Nikolakaki E; Dai T; Rubie EA; Ahmad MF; Avruch J; Woodgett JR
    Nature; 1994 May; 369(6476):156-60. PubMed ID: 8177321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis.
    Kodama Y; Taura K; Miura K; Schnabl B; Osawa Y; Brenner DA
    Gastroenterology; 2009 Apr; 136(4):1423-34. PubMed ID: 19249395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JNK1 is not essential for TNF-mediated joint disease.
    Köller M; Hayer S; Redlich K; Ricci R; David JP; Steiner G; Smolen JS; Wagner EF; Schett G
    Arthritis Res Ther; 2005; 7(1):R166-73. PubMed ID: 15642137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia.
    Waetzig V; Czeloth K; Hidding U; Mielke K; Kanzow M; Brecht S; Goetz M; Lucius R; Herdegen T; Hanisch UK
    Glia; 2005 May; 50(3):235-46. PubMed ID: 15739188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Jun is regulated by combination of enhanced expression and phosphorylation in acute-overloaded rat heart.
    Nadruz W; Kobarg CB; Kobarg J; Franchini KG
    Am J Physiol Heart Circ Physiol; 2004 Feb; 286(2):H760-7. PubMed ID: 14512277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nuclear tyrosine phosphorylation circuit: c-Jun as an activator and substrate of c-Abl and JNK.
    Barilá D; Mangano R; Gonfloni S; Kretzschmar J; Moro M; Bohmann D; Superti-Furga G
    EMBO J; 2000 Jan; 19(2):273-81. PubMed ID: 10637231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of MAP kinases in UVB-induced phosphorylation of p53 at serine 20.
    She QB; Ma WY; Dong Z
    Oncogene; 2002 Feb; 21(10):1580-9. PubMed ID: 11896587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the ATFa/JNK2 complex in Jun activation.
    De Graeve F; Bahr A; Sabapathy KT; Hauss C; Wagner EF; Kedinger C; Chatton B
    Oncogene; 1999 Jun; 18(23):3491-500. PubMed ID: 10376527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch.
    Gao M; Labuda T; Xia Y; Gallagher E; Fang D; Liu YC; Karin M
    Science; 2004 Oct; 306(5694):271-5. PubMed ID: 15358865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.